Page 5 - Read Online
P. 5

www.jcmtjournal.com




            Special Issue

            Cancer Immunotherapy



            Guest Editors:                    Special Issue Introduction
            Prof. Shuen-Kuei Liao             This special issue covering seven articles in the area of cancer
            The PhD Program for Cancer        Immunotherapy/biotherapy provides useful source information as well
            Biology and Drug Discovery,       as a landmark at an extremely exciting time in the development of
            Taipei Medical University,        many innovative immune/biological agents, such as non-specic
            Taipei 110, Taiwan, China.        immunomodulators, immune checkpoint molecules, humanized
                                              antibodies, genetically modied T cells and neoantigen/RNA
            E-mail: liaosk@h.tmu.edu.tw
                                              mutanome vaccines. The invited authors have covered the scientic
                                              principles, technologies, experimental models, clinical approaches and
                                              future directions in their own ways. We do not intend to remove areas
                                              of overlapping among articles particularly the review articles, so that a
                                              variety of perspectives could be presented on the different
                                              approaches to the many laboratory and clinical problems. Just as
                                              important, strategies with individualized and combinational (with any
                                              standard treatment) approaches for greater efcacies have been
                                              much emphasized in this type of treatment modality. While currently
                                              only small proportions of patients with selected cancer types refractory
                                              to the standard therapies have benetted, some major scientic,
                                              clinical and regulatory hurdles still need to be overcome in order to
                                              bring the full potential clinical benets in years to come. I sincerely
                                              hope that this special issue will give our readers a snapshot of this
                                              exciting and evolving new eld.


                                                Benets
                                                Open Access: the full-text of each published article can be
                                                accessed and downloaded from the journal website without any
                                                fee.
                                                Free of Charge: we strictly follow international guidelines (COPE
                                                Ethical Guidelines for Peer Reviewers) and ensure rigorous peer
                                                review process.
                                                Worldwide Readership: the readers of the journal are from more than
                                                167 countries worldwide.
                                                Wide Promotions: all published articles will be promoted on
                                                academic conferences, social networks for scientists or other various
                                                channels.







                                              245 E Main Street ste122, Alhambra, CA 91801, USA；  www.jcmtjournal.com/
                                              Tel：+1 323 9987086；E-mail：editorialoffice@jcmtjournal.com  journal/special_detail/126
   1   2   3   4   5   6   7   8   9   10